Luke Moore to Pneumonia, Viral
This is a "connection" page, showing publications Luke Moore has written about Pneumonia, Viral.
Connection Strength
0.116
-
Comparison of deep learning with regression analysis in creating predictive models for SARS-CoV-2 outcomes. BMC Med Inform Decis Mak. 2020 11 19; 20(1):299.
Score: 0.029
-
Serological assays for delayed SARS-CoV-2 case identification - Author's reply. Lancet Respir Med. 2020 10; 8(10):e74.
Score: 0.029
-
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect. 2020 Oct; 26(10):1395-1399.
Score: 0.028
-
Investigating the association between ethnicity and health outcomes in SARS-CoV-2 in a London secondary care population. PLoS One. 2020; 15(10):e0240960.
Score: 0.007
-
Cardiometabolic Traits, Sepsis, and Severe COVID-19: A Mendelian Randomization Investigation. Circulation. 2020 11 03; 142(18):1791-1793.
Score: 0.007
-
Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study. Lancet Respir Med. 2020 09; 8(9):885-894.
Score: 0.007
-
COVID-19 and the potential long-term impact on antimicrobial resistance. J Antimicrob Chemother. 2020 07 01; 75(7):1681-1684.
Score: 0.007
-
Antimicrobial use, drug-resistant infections and COVID-19. Nat Rev Microbiol. 2020 08; 18(8):409-410.
Score: 0.002